| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.734 | 0.005 | 0.734 | 5 Hydroxytryptamine release stimulant | 0.586 0.016 CID_154699837 | ||
| 0.659 | 0.012 | 0.659 | Aldehyde oxidase inhibitor | |||
| 0.661 | 0.028 | 0.661 | Caspase 9 stimulant | 0.62 0.034 CID_154699837 | ||
| 0.589 | 0.005 | 0.589 | Peroxidase inhibitor | |||
| 0.589 | 0.009 | 0.589 | GABA C receptor rho-3 antagonist | |||
| 0.55 | 0.004 | 0.55 | 5 Hydroxytryptamine uptake stimulant | 0.271 0.063 CID_154699837 | ||
| 0.512 | 0.005 | 0.525 | NOS3 expression enhancer | 0.525 0.005 CID_154699837 | CID_154699837 | |
| 0.53 | 0.024 | 0.598 | 5 Hydroxytryptamine release inhibitor | 0.598 0.011 CID_154699837 | CID_154699837 | |
| 0.473 | 0.004 | 0.473 | Alcohol oxidase inhibitor | 0.054 0.041 CID_154699837 | ||
| 0.467 | 0.016 | 0.467 | Superoxide dismutase inhibitor | |||
| 0.48 | 0.043 | 0.48 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.473 | 0.037 | 0.693 | Cholesterol antagonist | 0.693 0.008 CID_154699837 | CID_154699837 | |
| 0.438 | 0.003 | 0.438 | Creatine kinase inhibitor | 0.115 0.045 CID_154699837 | ||
| 0.438 | 0.005 | 0.438 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.435 | 0.004 | 0.435 | Estrogen antagonist | |||
| 0.433 | 0.004 | 0.433 | Estrogen receptor beta antagonist | |||
| 0.423 | 0.003 | 0.423 | Nitric-oxide synthase stimulant | 0.421 0.003 CID_154699837 | ||
| 0.418 | 0.008 | 0.65 | Alpha-N-acetylglucosaminidase inhibitor | 0.65 0.003 CID_154699837 | CID_154699837 | |
| 0.406 | 0.005 | 0.406 | Aldehyde dehydrogenase inhibitor | 0.351 0.008 CID_154699837 | ||
| 0.451 | 0.05 | 0.545 | Histamine release inhibitor | 0.545 0.017 CID_154699837 | CID_154699837 | |
| 0.491 | 0.091 | 0.848 | Antiinflammatory | 0.848 0.009 CID_154699837 | CID_154699837 | |
| 0.438 | 0.057 | 0.438 | Calcium channel L-type activator | |||
| 0.401 | 0.024 | 0.401 | Calcium channel activator | |||
| 0.38 | 0.005 | 0.38 | Cystathionine beta-synthase inhibitor | 0.321 0.008 CID_154699837 | ||
| 0.387 | 0.021 | 0.545 | Interleukin agonist | 0.545 0.006 CID_154699837 | CID_154699837 | |
| 0.369 | 0.006 | 0.369 | GABA C receptor agonist | 0.094 0.073 CID_154699837 | ||
| 0.369 | 0.021 | 0.369 | Anesthetic general | 0.347 0.024 CID_154699837 | ||
| 0.38 | 0.033 | 0.64 | Free radical scavenger | 0.64 0.007 CID_154699837 | CID_154699837 | |
| 0.352 | 0.005 | 0.352 | Ferrochelatase inhibitor | |||
| 0.358 | 0.012 | 0.688 | Amylase inhibitor | 0.688 0.003 CID_154699837 | CID_154699837 | |
| 0.357 | 0.029 | 0.513 | DNA synthesis inhibitor | 0.513 0.012 CID_154699837 | CID_154699837 | |
| 0.362 | 0.037 | 0.362 | Interleukin antagonist | |||
| 0.326 | 0.004 | 0.326 | Macrophage migration inhibitory factor inhibitor | |||
| 0.353 | 0.033 | 0.353 | Pyruvate kinase inhibitor | |||
| 0.363 | 0.043 | 0.7 | Antioxidant | 0.7 0.006 CID_154699837 | CID_154699837 | |
| 0.321 | 0.005 | 0.321 | Estrogen agonist | 0.083 0.022 CID_154699837 | ||
| 0.354 | 0.038 | 0.452 | Antiamyloidogenic | 0.452 0.021 CID_154699837 | CID_154699837 | |
| 0.321 | 0.005 | 0.424 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.424 0.003 CID_154699837 | CID_154699837 | |
| 0.325 | 0.013 | 0.333 | Neurotrophic factor enhancer | 0.333 0.011 CID_154699837 | CID_154699837 | |
| 0.391 | 0.078 | 0.391 | 15-Lipoxygenase inhibitor | |||
| 0.317 | 0.005 | 0.331 | Mannose-6-phosphate isomerase inhibitor | 0.331 0.004 CID_154699837 | CID_154699837 | |
| 0.326 | 0.017 | 0.326 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.256 0.04 CID_154699837 | ||
| 0.304 | 0.003 | 0.304 | DOPA decarboxylase inhibitor | 0.122 0.043 CID_154699837 | ||
| 0.3 | 0.004 | 0.3 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.321 | 0.028 | 0.321 | RNA-directed DNA polymerase inhibitor | 0.258 0.045 CID_154699837 | ||
| 0.298 | 0.005 | 0.529 | Triose-phosphate isomerase inhibitor | 0.529 0.002 CID_154699837 | CID_154699837 | |
| 0.321 | 0.028 | 0.321 | ErbB-1 antagonist | |||
| 0.389 | 0.097 | 0.872 | Cyclophilin D inhibitor | 0.872 0.005 CID_154699837 | CID_154699837 | |
| 0.31 | 0.017 | 0.31 | Phospholipase C inhibitor | 0.228 0.03 CID_154699837 | ||
| 0.339 | 0.051 | 0.497 | Interleukin 2 agonist | 0.497 0.008 CID_154699837 | CID_154699837 | |
| 0.317 | 0.03 | 0.317 | MAP kinase kinase 2 inhibitor | |||
| 0.293 | 0.013 | 0.293 | NADPH oxidase inhibitor | 0.221 0.028 CID_154699837 | ||
| 0.29 | 0.011 | 0.46 | UDP-glucose 4-epimerase inhibitor | 0.46 0.004 CID_154699837 | CID_154699837 | |
| 0.305 | 0.027 | 0.578 | Non-steroidal antiinflammatory agent | 0.578 0.005 CID_154699837 | CID_154699837 | |
| 0.321 | 0.045 | 0.321 | Transcription factor STAT inhibitor | |||
| 0.328 | 0.053 | 0.363 | Hypoxia-inducible factor 1 alpha inhibitor | 0.363 0.041 CID_154699837 | CID_154699837 | |
| 0.329 | 0.058 | 0.329 | Lipoxygenase inhibitor | |||
| 0.334 | 0.063 | 0.334 | 12-Lipoxygenase inhibitor | |||
| 0.284 | 0.013 | 0.284 | Succinate dehydrogenase inhibitor | 0.159 0.097 CID_154699837 | ||
| 0.29 | 0.021 | 0.465 | Interferon gamma antagonist | 0.465 0.008 CID_154699837 | CID_154699837 | |
| 0.316 | 0.048 | 0.759 | Hypoglycemic | 0.759 0.004 CID_154699837 | CID_154699837 | |
| 0.281 | 0.015 | 0.281 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.365 | 0.101 | 0.365 | Analgesic | |||
| 0.318 | 0.056 | 0.318 | Aryl hydrocarbon receptor agonist | |||
| 0.267 | 0.004 | 0.267 | 5 Hydroxytryptamine 3A agonist | |||
| 0.339 | 0.08 | 0.671 | Transcription factor NF kappa B inhibitor | 0.671 0.024 CID_154699837 | CID_154699837 | |
| 0.259 | 0.003 | 0.259 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.315 | 0.06 | 0.315 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.262 | 0.007 | 0.262 | Alcohol dehydrogenase inhibitor | 0.194 0.013 CID_154699837 | ||
| 0.262 | 0.007 | 0.262 | Porphobilinogen synthase inhibitor | |||
| 0.275 | 0.021 | 0.555 | Monophenol monooxygenase inhibitor | 0.555 0.006 CID_154699837 | CID_154699837 | |
| 0.258 | 0.004 | 0.258 | Estrogen receptor beta agonist | 0.036 0.022 CID_154699837 | ||
| 0.334 | 0.081 | 0.334 | Vasodilator, peripheral | 0.311 0.092 CID_154699837 | ||
| 0.272 | 0.019 | 0.272 | Histone acetyltransferase inhibitor | |||
| 0.288 | 0.038 | 0.288 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.273 | 0.025 | 0.459 | Melanin inhibitor | 0.459 0.009 CID_154699837 | CID_154699837 | |
| 0.303 | 0.056 | 0.303 | Insulysin inhibitor | |||
| 0.257 | 0.012 | 0.257 | Interleukin 4 antagonist | 0.177 0.031 CID_154699837 | ||
| 0.248 | 0.006 | 0.248 | CF transmembrane conductance regulator agonist | 0.186 0.031 CID_154699837 | ||
| 0.245 | 0.004 | 0.245 | Estrogen receptor alpha agonist | |||
| 0.244 | 0.005 | 0.244 | MAP kinase kinase 4 inhibitor | |||
| 0.343 | 0.106 | 0.663 | Antibacterial | 0.663 0.012 CID_154699837 | CID_154699837 | |
| 0.25 | 0.016 | 0.25 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.248 | 0.014 | 0.404 | ATPase inhibitor | 0.404 0.004 CID_154699837 | CID_154699837 | |
| 0.252 | 0.018 | 0.252 | Interleukin 1 antagonist | 0.11 0.105 CID_154699837 | ||
| 0.25 | 0.017 | 0.419 | Hexokinase inhibitor | 0.419 0.004 CID_154699837 | CID_154699837 | |
| 0.241 | 0.009 | 0.241 | Potassium channel (Ca-activated) activator | |||
| 0.28 | 0.049 | 0.28 | Amyloid beta aggregation inhibitor | 0.138 0.118 CID_154699837 | ||
| 0.234 | 0.004 | 0.234 | HIV-1 integrase inhibitor | 0.085 0.035 CID_154699837 | ||
| 0.232 | 0.003 | 0.232 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.235 | 0.007 | 0.235 | Interleukin 8 antagonist | 0.111 0.074 CID_154699837 | ||
| 0.232 | 0.006 | 0.232 | Keratolytic | |||
| 0.246 | 0.022 | 0.246 | Cyclooxygenase 1 inhibitor | 0.127 0.073 CID_154699837 | ||
| 0.225 | 0.004 | 0.225 | Myeloperoxidase inhibitor | |||
| 0.229 | 0.008 | 0.229 | GABA C receptor antagonist | |||
| 0.232 | 0.013 | 0.232 | Toll-Like receptor 2 antagonist | 0.103 0.1 CID_154699837 | ||
| 0.233 | 0.014 | 0.233 | Carbonic anhydrase XV inhibitor | |||
| 0.229 | 0.01 | 0.229 | Histidine decarboxylase inhibitor | |||
| 0.228 | 0.012 | 0.228 | Carbonic anhydrase III inhibitor | 0.122 0.043 CID_154699837 | ||
| 0.22 | 0.005 | 0.22 | Glutamate decarboxylase inhibitor | |||
| 0.234 | 0.02 | 0.234 | Cholesterol synthesis inhibitor | 0.167 0.037 CID_154699837 | ||
| 0.278 | 0.065 | 0.278 | Transcription factor STAT3 inhibitor | |||
| 0.229 | 0.017 | 0.229 | GABA C receptor rho-2 antagonist | |||
| 0.225 | 0.014 | 0.225 | Arachidonic acid antagonist | 0.176 0.059 CID_154699837 | ||
| 0.225 | 0.016 | 0.225 | Farnesoid X receptor antagonist | |||
| 0.233 | 0.024 | 0.233 | Neurotensin receptor agonist | |||
| 0.227 | 0.019 | 0.227 | 5-Lipoxygenase inhibitor | |||
| 0.215 | 0.007 | 0.215 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.212 | 0.004 | 0.236 | Glutamate release inhibitor | 0.236 0.004 CID_154699837 | CID_154699837 | |
| 0.297 | 0.09 | 0.48 | Vasodilator, coronary | 0.48 0.018 CID_154699837 | CID_154699837 | |
| 0.232 | 0.027 | 0.32 | Interleukin 6 antagonist | 0.32 0.012 CID_154699837 | CID_154699837 | |
| 0.223 | 0.019 | 0.223 | Catenin beta inhibitor | |||
| 0.218 | 0.014 | 0.218 | Nav1.6 sodium channel blocker | |||
| 0.233 | 0.03 | 0.233 | Cyclooxygenase inhibitor | 0.135 0.083 CID_154699837 | ||
| 0.236 | 0.035 | 0.236 | Tumour necrosis factor antagonist | |||
| 0.207 | 0.006 | 0.207 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.209 | 0.011 | 0.307 | Photosensitizer | 0.307 0.004 CID_154699837 | CID_154699837 | |
| 0.284 | 0.087 | 0.342 | Caspase 3 stimulant | 0.342 0.062 CID_154699837 | CID_154699837 | |
| 0.224 | 0.029 | 0.343 | Topoisomerase II inhibitor | 0.343 0.014 CID_154699837 | CID_154699837 | |
| 0.206 | 0.012 | 0.586 | Beta glucuronidase inhibitor | 0.586 0.003 CID_154699837 | CID_154699837 | |
| 0.288 | 0.094 | 0.561 | Apoptosis antagonist | 0.561 0.014 CID_154699837 | CID_154699837 | |
| 0.207 | 0.015 | 0.229 | Beta amyloid protein antagonist | 0.229 0.01 CID_154699837 | CID_154699837 | |
| 0.2 | 0.01 | 0.2 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.193 | 0.005 | 0.193 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.212 | 0.024 | 0.212 | MAP kinase kinase inhibitor | |||
| 0.246 | 0.06 | 0.246 | Neuropeptide Y2 antagonist | |||
| 0.193 | 0.008 | 0.193 | Transcription factor STAT6 inhibitor | |||
| 0.195 | 0.011 | 0.396 | NADH dehydrogenase inhibitor | 0.396 0.005 CID_154699837 | CID_154699837 | |
| 0.21 | 0.026 | 0.405 | Cell wall synthesis inhibitor | 0.405 0.006 CID_154699837 | CID_154699837 | |
| 0.212 | 0.029 | 0.219 | Alkaline phosphatase inhibitor | 0.219 0.027 CID_154699837 | CID_154699837 | |
| 0.186 | 0.004 | 0.186 | D-Ala-D-Ala ligase inhibitor | |||
| 0.195 | 0.013 | 0.195 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.254 | 0.073 | 0.546 | Tumour necrosis factor alpha release inhibitor | 0.546 0.01 CID_154699837 | CID_154699837 | |
| 0.195 | 0.016 | 0.195 | Catalase inhibitor | |||
| 0.331 | 0.151 | 0.636 | Apoptosis agonist | 0.636 0.042 CID_154699837 | CID_154699837 | |
| 0.186 | 0.006 | 0.186 | NMDA 2B receptor antagonist | |||
| 0.215 | 0.036 | 0.215 | MAO inhibitor | |||
| 0.247 | 0.069 | 0.42 | Hypolipemic | 0.42 0.022 CID_154699837 | CID_154699837 | |
| 0.277 | 0.101 | 0.277 | Sodium/bile acid cotransporter inhibitor | |||
| 0.191 | 0.018 | 0.191 | Adenylate cyclase stimulant | 0.136 0.089 CID_154699837 | ||
| 0.18 | 0.007 | 0.18 | Ca2+-transporting ATPase inhibitor | 0.175 0.01 CID_154699837 | ||
| 0.215 | 0.044 | 0.215 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.196 | 0.026 | 0.196 | Adenylate cyclase inhibitor | 0.131 0.058 CID_154699837 | ||
| 0.181 | 0.014 | 0.532 | AMP-activated protein kinase stimulant | 0.532 0.003 CID_154699837 | CID_154699837 | |
| 0.182 | 0.015 | 0.182 | Carbonic anhydrase VI inhibitor | 0.078 0.06 CID_154699837 | ||
| 0.189 | 0.022 | 0.284 | Xanthine oxidase inhibitor | 0.284 0.009 CID_154699837 | CID_154699837 | |
| 0.214 | 0.048 | 0.214 | Lipocortins synthesis antagonist | 0.179 0.072 CID_154699837 | ||
| 0.181 | 0.016 | 0.181 | Androgen antagonist | |||
| 0.208 | 0.043 | 0.208 | Antipruritic | |||
| 0.188 | 0.024 | 0.188 | MAP kinase 13 inhibitor | |||
| 0.166 | 0.003 | 0.166 | Dopamine beta hydroxylase inhibitor | |||
| 0.315 | 0.152 | 0.573 | Alpha-glucosidase inhibitor | 0.573 0.06 CID_154699837 | CID_154699837 | |
| 0.168 | 0.005 | 0.168 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.179 | 0.018 | 0.179 | Adenylate kinase inhibitor | 0.144 0.029 CID_154699837 | ||
| 0.171 | 0.012 | 0.205 | Toll-Like receptor 4 antagonist | 0.205 0.005 CID_154699837 | CID_154699837 | |
| 0.172 | 0.016 | 0.178 | Heat shock protein 70 antagonist | 0.178 0.013 CID_154699837 | CID_154699837 | |
| 0.166 | 0.01 | 0.166 | Estrogen receptor alpha antagonist | |||
| 0.169 | 0.014 | 0.169 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.197 | 0.043 | 0.351 | Lipid peroxidase inhibitor | 0.351 0.013 CID_154699837 | CID_154699837 | |
| 0.165 | 0.011 | 0.165 | MAP kinase kinase 1 inhibitor | |||
| 0.182 | 0.028 | 0.182 | MAP kinase 12 inhibitor | |||
| 0.168 | 0.015 | 0.168 | GABA C receptor rho-1 antagonist | |||
| 0.174 | 0.023 | 0.174 | Pregnane X receptor agonist | |||
| 0.158 | 0.007 | 0.158 | GABA aminotransferase inhibitor | 0.14 0.01 CID_154699837 | ||
| 0.17 | 0.019 | 0.17 | NMDA receptor antagonist | |||
| 0.166 | 0.015 | 0.29 | Phosphofructokinase-1 inhibitor | 0.29 0.006 CID_154699837 | CID_154699837 | |
| 0.18 | 0.029 | 0.18 | MAO B inhibitor | |||
| 0.192 | 0.041 | 0.192 | Death-associated protein kinase 2 inhibitor | |||
| 0.205 | 0.054 | 0.205 | Amyloid beta precursor protein antagonist | |||
| 0.25 | 0.1 | 0.25 | Ca(v)3.3 blocker | |||
| 0.166 | 0.016 | 0.166 | Prolactin inhibitor | |||
| 0.184 | 0.036 | 0.184 | Cyclooxygenase 2 inhibitor | 0.11 0.091 CID_154699837 | ||
| 0.186 | 0.039 | 0.522 | Hemostatic | 0.522 0.004 CID_154699837 | CID_154699837 | |
| 0.162 | 0.014 | 0.162 | NMDA 2 receptor antagonist | |||
| 0.276 | 0.13 | 0.276 | Calpain 2 inhibitor | |||
| 0.174 | 0.028 | 0.174 | Aminopeptidase B inhibitor | |||
| 0.19 | 0.045 | 0.352 | Protein kinase stimulant | 0.352 0.012 CID_154699837 | CID_154699837 | |
| 0.174 | 0.031 | 0.467 | Cyclooxygenase 3 inhibitor | 0.467 0.003 CID_154699837 | CID_154699837 | |
| 0.146 | 0.003 | 0.146 | Glutamate (mGluR1a) agonist | |||
| 0.151 | 0.009 | 0.151 | TRPA1 antagonist | |||
| 0.163 | 0.023 | 0.163 | TRPA1 agonist | 0.1 0.087 CID_154699837 | ||
| 0.15 | 0.011 | 0.15 | Potassium channel large-conductance Ca-activated activator | |||
| 0.245 | 0.106 | 0.245 | Streptokinase A inhibitor | |||
| 0.154 | 0.016 | 0.154 | Anabolic | 0.09 0.078 CID_154699837 | ||
| 0.204 | 0.068 | 0.204 | I kappa B kinase epsilon inhibitor | |||
| 0.147 | 0.013 | 0.151 | Interleukin 12 antagonist | 0.151 0.012 CID_154699837 | CID_154699837 | |
| 0.154 | 0.021 | 0.154 | Urease inhibitor | |||
| 0.138 | 0.005 | 0.138 | Estrogen-related receptor beta agonist | |||
| 0.146 | 0.013 | 0.146 | Glutamate (mGluR7) agonist | |||
| 0.143 | 0.01 | 0.143 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.18 | 0.049 | 0.18 | Heat shock protein 90 antagonist | |||
| 0.202 | 0.071 | 0.202 | Insulin sensitizer | 0.198 0.076 CID_154699837 | ||
| 0.139 | 0.009 | 0.139 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.137 0.009 CID_154699837 | ||
| 0.15 | 0.02 | 0.15 | Potassium channel activator | |||
| 0.133 | 0.005 | 0.133 | GABA B receptor agonist | |||
| 0.132 | 0.004 | 0.132 | Phospholipase D inhibitor | 0.077 0.039 CID_154699837 | ||
| 0.192 | 0.065 | 0.192 | Dual specificity phosphatase 3 inhibitor | |||
| 0.164 | 0.037 | 0.164 | Cathepsin H inhibitor | |||
| 0.132 | 0.006 | 0.132 | Topoisomerase II beta inhibitor | 0.09 0.011 CID_154699837 | ||
| 0.138 | 0.013 | 0.215 | Phosphodiesterase 6D inhibitor | 0.215 0.004 CID_154699837 | CID_154699837 | |
| 0.157 | 0.032 | 0.157 | Vanilloid 1 agonist | 0.144 0.045 CID_154699837 | ||
| 0.159 | 0.034 | 0.159 | Interleukin 1b antagonist | 0.111 0.069 CID_154699837 | ||
| 0.135 | 0.011 | 0.19 | Glycine receptor antagonist | 0.19 0.004 CID_154699837 | CID_154699837 | |
| 0.129 | 0.005 | 0.129 | CC chemokine 5 receptor agonist | |||
| 0.194 | 0.071 | 0.194 | TRKC antagonist | |||
| 0.183 | 0.06 | 0.183 | Heat shock protein 90 alpha antagonist | |||
| 0.125 | 0.004 | 0.125 | Glutamate (mGluR7) antagonist | |||
| 0.13 | 0.01 | 0.13 | Purinergic P2X1 antagonist | 0.067 0.035 CID_154699837 | ||
| 0.123 | 0.004 | 0.123 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.136 | 0.017 | 0.136 | Dopamine D1 antagonist | |||
| 0.17 | 0.052 | 0.17 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.122 | 0.003 | 0.122 | Dopamine D5 agonist | |||
| 0.131 | 0.013 | 0.14 | Aldose reductase inhibitor | 0.14 0.012 CID_154699837 | CID_154699837 | |
| 0.15 | 0.032 | 0.16 | Mucolytic | 0.16 0.027 CID_154699837 | CID_154699837 | |
| 0.14 | 0.024 | 0.146 | Carbonic anhydrase XIII inhibitor | 0.146 0.022 CID_154699837 | CID_154699837 | |
| 0.146 | 0.031 | 0.146 | Caspase 3 inhibitor | |||
| 0.166 | 0.051 | 0.166 | Cytokine production inhibitor | |||
| 0.22 | 0.105 | 0.328 | Spasmolytic | 0.328 0.06 CID_154699837 | CID_154699837 | |
| 0.187 | 0.073 | 0.497 | Nitric oxide antagonist | 0.497 0.016 CID_154699837 | CID_154699837 | |
| 0.122 | 0.009 | 0.122 | 5 Hydroxytryptamine 2A agonist | |||
| 0.128 | 0.014 | 0.128 | Carbamoyl phosphate synthetase inhibitor | 0.075 0.031 CID_154699837 | ||
| 0.163 | 0.05 | 0.163 | Nav1.2 sodium channel blocker | |||
| 0.153 | 0.04 | 0.153 | MAO A inhibitor | |||
| 0.117 | 0.005 | 0.117 | MAP kinase kinase 7 inhibitor | |||
| 0.114 | 0.003 | 0.114 | Adenylate cyclase 1 inhibitor | |||
| 0.13 | 0.019 | 0.13 | Carbonic anhydrase V inhibitor | |||
| 0.178 | 0.069 | 0.178 | Dual specificity phosphatase inhibitor | |||
| 0.115 | 0.006 | 0.115 | Kinesin antagonist | |||
| 0.115 | 0.006 | 0.115 | Kinesin-like protein 1 inhibitor | |||
| 0.147 | 0.038 | 0.147 | GABA receptor agonist | |||
| 0.129 | 0.022 | 0.129 | Adrenaline agonist | |||
| 0.127 | 0.021 | 0.127 | Glutamate dehydrogenase inhibitor | 0.089 0.037 CID_154699837 | ||
| 0.144 | 0.038 | 0.144 | Chelator | |||
| 0.121 | 0.015 | 0.121 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.131 | 0.025 | 0.163 | Thioredoxin inhibitor | 0.163 0.014 CID_154699837 | CID_154699837 | |
| 0.121 | 0.016 | 0.121 | HIV-1 integrase (Strand Transfer) inhibitor | 0.063 0.04 CID_154699837 | ||
| 0.117 | 0.013 | 0.117 | Carbonic anhydrase VB inhibitor | |||
| 0.106 | 0.003 | 0.106 | Pregnane X receptor antagonist | |||
| 0.107 | 0.005 | 0.107 | CXC chemokine 1 receptor antagonist | |||
| 0.12 | 0.018 | 0.12 | Carbonic anhydrase VA inhibitor | |||
| 0.22 | 0.119 | 0.22 | Gastrin inhibitor | |||
| 0.11 | 0.01 | 0.11 | Vanilloid 4 agonist | |||
| 0.112 | 0.013 | 0.112 | Secretase beta inhibitor | |||
| 0.237 | 0.137 | 0.659 | Antithrombotic | 0.659 0.011 CID_154699837 | CID_154699837 | |
| 0.103 | 0.004 | 0.103 | Alpha 1d adrenoreceptor agonist | |||
| 0.129 | 0.03 | 0.129 | Electrolyte absorption antagonist | |||
| 0.141 | 0.043 | 0.192 | Microtubule formation inhibitor | 0.192 0.022 CID_154699837 | CID_154699837 | |
| 0.109 | 0.01 | 0.109 | Aryl hydrocarbon receptor antagonist | |||
| 0.151 | 0.053 | 0.151 | Sodium channel (voltage-gated) blocker | |||
| 0.101 | 0.003 | 0.101 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.206 | 0.108 | 0.206 | Calpain inhibitor | |||
| 0.141 | 0.045 | 0.294 | Topoisomerase I inhibitor | 0.294 0.011 CID_154699837 | CID_154699837 | |
| 0.116 | 0.02 | 0.116 | HIV-1 integrase (3'-Processing) inhibitor | 0.058 0.049 CID_154699837 | ||
| 0.111 | 0.015 | 0.111 | Glycine receptor agonist | 0.098 0.022 CID_154699837 | ||
| 0.103 | 0.008 | 0.103 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.103 | 0.008 | 0.103 | Aconitate hydratase inhibitor | |||
| 0.11 | 0.016 | 0.11 | Biliverdin reductase inhibitor | 0.075 0.029 CID_154699837 | ||
| 0.135 | 0.041 | 0.135 | Nav1.4 sodium channel blocker | |||
| 0.103 | 0.009 | 0.103 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.104 | 0.01 | 0.104 | NMDA receptor subunit 3B antagonist | |||
| 0.138 | 0.044 | 0.262 | DNA repair enzyme inhibitor | 0.262 0.005 CID_154699837 | CID_154699837 | |
| 0.127 | 0.034 | 0.184 | Uric acid excretion stimulant | 0.184 0.015 CID_154699837 | CID_154699837 | |
| 0.163 | 0.07 | 0.163 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.104 | 0.012 | 0.104 | Glycine transporter 2 inhibitor | |||
| 0.105 | 0.013 | 0.105 | Beta 3 adrenoreceptor antagonist | |||
| 0.116 | 0.024 | 0.116 | Bile acid receptor antagonist | |||
| 0.1 | 0.008 | 0.1 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.132 | 0.041 | 0.132 | Nav1.5 sodium channel blocker | |||
| 0.174 | 0.083 | 0.286 | DNA methyltransferase I inhibitor | 0.286 0.031 CID_154699837 | CID_154699837 | |
| 0.104 | 0.013 | 0.104 | Androgen agonist | |||
| 0.103 | 0.014 | 0.103 | 5 Hydroxytryptamine 3 agonist | |||
| 0.131 | 0.042 | 0.131 | Nav1.1 sodium channel blocker | |||
| 0.1 | 0.011 | 0.1 | Fatty acid synthase inhibitor | |||
| 0.205 | 0.117 | 0.498 | Immunostimulant | 0.498 0.029 CID_154699837 | CID_154699837 | |
| 0.097 | 0.009 | 0.097 | Sphingosine kinase 2 inhibitor | |||
| 0.157 | 0.068 | 0.157 | Acetylcholine M1 receptor antagonist | |||
| 0.099 | 0.011 | 0.099 | Glutamate (mGluR6) antagonist | 0.069 0.043 CID_154699837 | ||
| 0.152 | 0.064 | 0.152 | MAP kinase 3 inhibitor | |||
| 0.116 | 0.029 | 0.116 | MAP kinase 14 inhibitor | |||
| 0.141 | 0.054 | 0.141 | Nav1.3 sodium channel blocker | |||
| 0.095 | 0.008 | 0.095 | Transcription factor RelA inhibitor | |||
| 0.155 | 0.069 | 0.155 | Phospholipase A2 inhibitor | 0.136 0.091 CID_154699837 | ||
| 0.097 | 0.012 | 0.097 | Heat shock protein 90 beta antagonist | |||
| 0.12 | 0.035 | 0.12 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.095 | 0.011 | 0.095 | Exportin-1 inhibitor | |||
| 0.09 | 0.007 | 0.09 | Dihydroorotate oxidase inhibitor | |||
| 0.115 | 0.032 | 0.218 | Topoisomerase II alpha inhibitor | 0.218 0.013 CID_154699837 | CID_154699837 | |
| 0.096 | 0.012 | 0.096 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.093 | 0.01 | 0.093 | Dopamine D5 antagonist | |||
| 0.103 | 0.02 | 0.103 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.119 | 0.036 | 0.119 | Hepatocyte growth factor antagonist | |||
| 0.14 | 0.058 | 0.14 | Glutamate receptor antagonist | |||
| 0.187 | 0.104 | 0.332 | Cyclic AMP phosphodiesterase inhibitor | 0.332 0.031 CID_154699837 | CID_154699837 | |
| 0.107 | 0.024 | 0.107 | Aminopeptidase I inhibitor | |||
| 0.106 | 0.024 | 0.106 | Thioredoxin reductase inhibitor | |||
| 0.199 | 0.116 | 0.225 | DNA damaging | 0.225 0.097 CID_154699837 | CID_154699837 | |
| 0.086 | 0.005 | 0.086 | Glutamate (mGluR3) antagonist | |||
| 0.096 | 0.015 | 0.113 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.113 0.012 CID_154699837 | CID_154699837 | |
| 0.097 | 0.017 | 0.097 | Acyl-CoA dehydrogenase inhibitor | 0.051 0.041 CID_154699837 | ||
| 0.132 | 0.053 | 0.132 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.126 | 0.047 | 0.375 | Expectorant | 0.375 0.005 CID_154699837 | CID_154699837 | |
| 0.086 | 0.007 | 0.131 | Glucose-6-phosphate isomerase inhibitor | 0.131 0.003 CID_154699837 | CID_154699837 | |
| 0.085 | 0.005 | 0.085 | Nicotinic acid receptor agonist | |||
| 0.083 | 0.004 | 0.083 | CXC chemokine 2 receptor antagonist | |||
| 0.11 | 0.031 | 0.11 | Glutamate receptor agonist | |||
| 0.088 | 0.01 | 0.088 | Potassium channel Kv1.3 blocker | |||
| 0.087 | 0.009 | 0.273 | Alpha-mannosidase inhibitor | 0.273 0.002 CID_154699837 | CID_154699837 | |
| 0.138 | 0.06 | 0.138 | Protein kinase (CK1) delta inhibitor | |||
| 0.099 | 0.022 | 0.099 | Aromatase inhibitor | |||
| 0.094 | 0.018 | 0.094 | Xanthine dehydrogenase inhibitor | |||
| 0.174 | 0.098 | 0.293 | DNA methylase inhibitor | 0.293 0.03 CID_154699837 | CID_154699837 | |
| 0.097 | 0.022 | 0.097 | Acetylcholine M5 receptor agonist | |||
| 0.102 | 0.026 | 0.102 | Caspase 7 inhibitor | |||
| 0.093 | 0.019 | 0.093 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.103 | 0.029 | 0.124 | Na+ K+ transporting ATPase inhibitor | 0.124 0.014 CID_154699837 | CID_154699837 | |
| 0.112 | 0.039 | 0.112 | Potassium channel (Voltage-sensitive) activator | |||
| 0.116 | 0.044 | 0.116 | Sphingomyelinase inhibitor | 0.106 0.053 CID_154699837 | ||
| 0.089 | 0.018 | 0.089 | Potassium channel (Tandem pore domain) blocker | |||
| 0.102 | 0.031 | 0.102 | mTOR complex 2 inhibitor | |||
| 0.132 | 0.062 | 0.164 | CC chemokine 6 receptor antagonist | 0.164 0.01 CID_154699837 | CID_154699837 | |
| 0.104 | 0.034 | 0.104 | Glutathione S-transferase inhibitor | |||
| 0.138 | 0.067 | 0.138 | Sodium channel blocker | |||
| 0.09 | 0.02 | 0.09 | NMDA 2C receptor antagonist | |||
| 0.079 | 0.009 | 0.079 | Dihydroorotase inhibitor | |||
| 0.085 | 0.014 | 0.085 | Botulinum neurotoxin type A inhibitor | |||
| 0.177 | 0.107 | 0.838 | Angiogenesis stimulant | 0.838 0.003 CID_154699837 | CID_154699837 | |
| 0.104 | 0.034 | 0.104 | Inducible nitric-oxide synthase inhibitor | |||
| 0.159 | 0.089 | 0.159 | LIM domain kinase 1 inhibitor | |||
| 0.078 | 0.009 | 0.078 | Potassium channel (Inward rectifier) activator | |||
| 0.087 | 0.018 | 0.087 | Alpha tubulin antagonist | |||
| 0.09 | 0.022 | 0.09 | Argininosuccinate synthase inhibitor | 0.063 0.035 CID_154699837 | ||
| 0.109 | 0.041 | 0.109 | Protein kinase C zeta inhibitor | |||
| 0.075 | 0.008 | 0.075 | Purinergic P2X4 antagonist | |||
| 0.074 | 0.008 | 0.074 | Potassium channel (ATP-sensitive) activator | |||
| 0.076 | 0.01 | 0.263 | Mannosidase inhibitor | 0.263 0.002 CID_154699837 | CID_154699837 | |
| 0.088 | 0.022 | 0.088 | Carbonic anhydrase stimulant | |||
| 0.108 | 0.042 | 0.108 | Opioid antagonist | |||
| 0.077 | 0.012 | 0.077 | NMDA receptor subunit 3A antagonist | |||
| 0.102 | 0.039 | 0.102 | Interleukin 5 antagonist | 0.096 0.046 CID_154699837 | ||
| 0.079 | 0.017 | 0.079 | Sphingosine kinase inhibitor | |||
| 0.075 | 0.013 | 0.075 | Beta 2 adrenoreceptor agonist | |||
| 0.07 | 0.009 | 0.07 | Liver X receptor alpha agonist | |||
| 0.065 | 0.004 | 0.065 | Estrogen-related receptor beta antagonist | |||
| 0.08 | 0.02 | 0.08 | MDM2 inhibitor | |||
| 0.115 | 0.055 | 0.138 | Multidrug resistance-associated protein 1 inhibitor | 0.138 0.032 CID_154699837 | CID_154699837 | |
| 0.065 | 0.005 | 0.079 | Uridine phosphorylase inhibitor | 0.079 0.004 CID_154699837 | CID_154699837 | |
| 0.077 | 0.017 | 0.077 | Calcium channel P-type blocker | |||
| 0.073 | 0.013 | 0.086 | Adenine nucleotide translocase inhibitor | 0.086 0.007 CID_154699837 | CID_154699837 | |
| 0.098 | 0.039 | 0.098 | GABA A receptor agonist | |||
| 0.065 | 0.006 | 0.065 | Glutamate (mGluR8) agonist | |||
| 0.144 | 0.085 | 0.153 | Protein-tyrosine phosphatase inhibitor | 0.153 0.075 CID_154699837 | CID_154699837 | |
| 0.078 | 0.019 | 0.078 | Beta 1 adrenoreceptor antagonist | |||
| 0.083 | 0.025 | 0.083 | Potassium channel (ATP-sensitive) blocker | |||
| 0.091 | 0.033 | 0.091 | Nav1.8 sodium channel blocker | |||
| 0.09 | 0.033 | 0.09 | Opioid delta receptor antagonist | |||
| 0.062 | 0.005 | 0.062 | Vanilloid 3 antagonist | |||
| 0.06 | 0.003 | 0.06 | Estrogen-related receptor gamma antagonist | |||
| 0.066 | 0.008 | 0.066 | RNA-directed RNA polymerase inhibitor | |||
| 0.088 | 0.031 | 0.088 | Amidase inhibitor | |||
| 0.082 | 0.025 | 0.082 | Beta adrenoreceptor antagonist | |||
| 0.1 | 0.044 | 0.1 | Ornithine decarboxylase inhibitor | 0.076 0.072 CID_154699837 | ||
| 0.061 | 0.005 | 0.061 | Free fatty acid receptor 1 antagonist | |||
| 0.09 | 0.034 | 0.09 | Lipase inhibitor | |||
| 0.071 | 0.015 | 0.071 | Glutamate (mGluR group III) agonist | |||
| 0.06 | 0.005 | 0.06 | CF transmembrane conductance regulator antagonist | |||
| 0.101 | 0.045 | 0.101 | Histamine N-methyltransferase inhibitor | |||
| 0.063 | 0.008 | 0.063 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.063 | 0.009 | 0.07 | Guanylate cyclase inhibitor | 0.07 0.005 CID_154699837 | CID_154699837 | |
| 0.083 | 0.028 | 0.083 | Beta tubulin antagonist | |||
| 0.147 | 0.093 | 0.147 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.07 | 0.017 | 0.07 | Beta 2 adrenoreceptor antagonist | |||
| 0.057 | 0.004 | 0.057 | Glutamate (mGluR1) agonist | |||
| 0.077 | 0.025 | 0.077 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.058 | 0.005 | 0.058 | ATP citrate lysase inhibitor | |||
| 0.068 | 0.016 | 0.068 | Leukotriene C antagonist | |||
| 0.071 | 0.019 | 0.071 | 5 Hydroxytryptamine 7 agonist | |||
| 0.063 | 0.011 | 0.063 | GABA B receptor antagonist | |||
| 0.068 | 0.016 | 0.068 | CD45 antagonist | |||
| 0.075 | 0.023 | 0.075 | Cyclin D1 inhibitor | |||
| 0.064 | 0.012 | 0.064 | AICAR transformylase inhibitor | |||
| 0.1 | 0.048 | 0.1 | Calcium antagonist | |||
| 0.054 | 0.002 | 0.054 | Nicotinic acid receptor 1 antagonist | |||
| 0.055 | 0.004 | 0.055 | Alpha 2a adrenoreceptor agonist | |||
| 0.064 | 0.013 | 0.064 | Progesterone antagonist | |||
| 0.069 | 0.019 | 0.069 | Ryanodine receptor antagonist | |||
| 0.068 | 0.018 | 0.068 | Glutamate (mGluR group I) agonist | |||
| 0.07 | 0.02 | 0.108 | Carbonic anhydrase XIV inhibitor | 0.108 0.009 CID_154699837 | CID_154699837 | |
| 0.137 | 0.088 | 0.383 | Insulin secretagoues | 0.383 0.007 CID_154699837 | CID_154699837 | |
| 0.059 | 0.01 | 0.059 | DNA gyrase subunit A inhibitor | |||
| 0.063 | 0.014 | 0.063 | Oxytocin agonist | |||
| 0.055 | 0.007 | 0.055 | Liver X receptor beta antagonist | |||
| 0.058 | 0.009 | 0.058 | 5 Hydroxytryptamine 2B agonist | |||
| 0.092 | 0.044 | 0.092 | Opioid kappa receptor antagonist | |||
| 0.079 | 0.031 | 0.079 | Protein kinase C beta inhibitor | |||
| 0.052 | 0.004 | 0.052 | Glutamate (mGluR3) agonist | |||
| 0.071 | 0.024 | 0.071 | NMDA 2A receptor antagonist | |||
| 0.064 | 0.017 | 0.275 | Heparanase inhibitor | 0.275 0.002 CID_154699837 | CID_154699837 | |
| 0.083 | 0.036 | 0.083 | Alpha adrenoreceptor agonist | |||
| 0.163 | 0.115 | 0.163 | Growth factor agonist | |||
| 0.056 | 0.009 | 0.056 | HCV NS5B polymerase inhibitor | |||
| 0.077 | 0.03 | 0.077 | CDC25B inhibitor | |||
| 0.114 | 0.067 | 0.114 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.074 | 0.028 | 0.074 | Dopamine uptake inhibitor | |||
| 0.067 | 0.021 | 0.067 | 5 Hydroxytryptamine 2 agonist | |||
| 0.054 | 0.008 | 0.054 | Catechol O-methyltransferase inhibitor | |||
| 0.084 | 0.038 | 0.084 | Opioid mu receptor antagonist | |||
| 0.111 | 0.065 | 0.119 | Acetylcholine release stimulant | 0.119 0.05 CID_154699837 | CID_154699837 | |
| 0.064 | 0.018 | 0.064 | Immunoglobulin Fc receptor antagonist | |||
| 0.084 | 0.039 | 0.084 | CDC25A inhibitor | |||
| 0.082 | 0.036 | 0.082 | Leukotriene synthesis inhibitor | |||
| 0.091 | 0.045 | 0.091 | Vanilloid agonist | |||
| 0.156 | 0.111 | 0.163 | Psychostimulant | 0.163 0.106 CID_154699837 | CID_154699837 | |
| 0.088 | 0.043 | 0.088 | CYP2A6 inhibitor | |||
| 0.059 | 0.014 | 0.059 | Geranyltranstransferase inhibitor | |||
| 0.063 | 0.018 | 0.063 | Squalene epoxidase inhibitor | |||
| 0.053 | 0.008 | 0.053 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.066 | 0.021 | 0.066 | Lysine-specific demethylase 1A inhibitor | |||
| 0.135 | 0.091 | 0.135 | Neuropeptide Y1 antagonist | |||
| 0.05 | 0.007 | 0.05 | Ceramide glucosyltransferase inhibitor | 0.05 0.007 CID_154699837 | ||
| 0.054 | 0.01 | 0.054 | Kainate receptor agonist | |||
| 0.07 | 0.026 | 0.07 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.061 | 0.017 | 0.061 | Glutamate (mGluR5) agonist | |||
| 0.087 | 0.043 | 0.087 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.075 | 0.032 | 0.075 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.092 | 0.049 | 0.208 | Transcription factor NF kappa B stimulant | 0.208 0.009 CID_154699837 | CID_154699837 | |
| 0.065 | 0.022 | 0.065 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.094 | 0.052 | 0.094 | Pim-3 kinase inhibitor | |||
| 0.054 | 0.013 | 0.054 | GABA uptake inhibitor | |||
| 0.05 | 0.009 | 0.05 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.067 | 0.026 | 0.067 | Ca(v)3.2 blocker | |||
| 0.06 | 0.019 | 0.06 | Sodium/calcium exchanger inhibitor | |||
| 0.071 | 0.031 | 0.071 | Alpha 2 adrenoreceptor agonist | |||
| 0.044 | 0.004 | 0.044 | Nicotinic acid receptor 2 antagonist | |||
| 0.123 | 0.083 | 0.123 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.063 | 0.024 | 0.063 | Epithelial sodium channel blocker | |||
| 0.106 | 0.067 | 0.106 | Protein kinase C gamma inhibitor | |||
| 0.091 | 0.053 | 0.091 | Bromodomain-containing protein 2 inhibitor | |||
| 0.062 | 0.024 | 0.196 | Phosphorylase inhibitor | 0.196 0.005 CID_154699837 | CID_154699837 | |
| 0.085 | 0.046 | 0.085 | Ca(v)3.1 blocker | |||
| 0.084 | 0.045 | 0.084 | MAP kinase 11 inhibitor | |||
| 0.102 | 0.064 | 0.102 | Gastric antisecretory | |||
| 0.052 | 0.015 | 0.052 | Glutamate (mGluR group II) antagonist | |||
| 0.08 | 0.042 | 0.088 | Phosphodiesterase VI inhibitor | 0.088 0.03 CID_154699837 | CID_154699837 | |
| 0.051 | 0.013 | 0.051 | Fumarate hydratase inhibitor | 0.038 0.02 CID_154699837 | ||
| 0.108 | 0.071 | 0.151 | Protein-tyrosine phosphatase 1B inhibitor | 0.151 0.045 CID_154699837 | CID_154699837 | |
| 0.052 | 0.015 | 0.052 | TRPM8 blocker | |||
| 0.082 | 0.045 | 0.082 | Analgesic, opioid | |||
| 0.048 | 0.011 | 0.048 | Liver X receptor beta agonist | |||
| 0.112 | 0.075 | 0.112 | Calcium channel N-type blocker | |||
| 0.046 | 0.01 | 0.046 | HMG CoA reductase inhibitor | 0.037 0.018 CID_154699837 | ||
| 0.057 | 0.022 | 0.057 | Mineralocorticoid receptor antagonist | |||
| 0.131 | 0.095 | 0.131 | Thiol protease inhibitor | |||
| 0.112 | 0.076 | 0.112 | Acetylcholine muscarinic antagonist | |||
| 0.049 | 0.014 | 0.049 | Potassium channel Kv1.1 blocker | |||
| 0.051 | 0.016 | 0.051 | Dihydropteroate synthase inhibitor | |||
| 0.068 | 0.033 | 0.068 | Acetylcholine M5 receptor antagonist | |||
| 0.049 | 0.014 | 0.049 | Heme oxygenase inhibitor | |||
| 0.043 | 0.008 | 0.043 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.118 | 0.084 | 0.118 | Antibacterial (Helicobacter pylori) | |||
| 0.052 | 0.018 | 0.052 | Urate transporter 1 inhibitor | |||
| 0.076 | 0.042 | 0.076 | Prostaglandin-E synthase inhibitor | |||
| 0.061 | 0.027 | 0.095 | Leukotriene B4 antagonist | 0.095 0.011 CID_154699837 | CID_154699837 | |
| 0.049 | 0.015 | 0.049 | Diamine oxidase inhibitor | |||
| 0.047 | 0.013 | 0.047 | Delayed rectifier potassium channel blocker | |||
| 0.045 | 0.011 | 0.045 | Prostaglandin agonist | |||
| 0.068 | 0.034 | 0.068 | Prostaglandin F2 alpha antagonist | |||
| 0.056 | 0.022 | 0.056 | Cholesterol esterase inhibitor | |||
| 0.044 | 0.01 | 0.044 | Protein kinase (CK2) beta inhibitor | |||
| 0.049 | 0.015 | 0.049 | Glucocorticoid antagonist | |||
| 0.038 | 0.005 | 0.038 | Hedgehog signaling activator | |||
| 0.073 | 0.04 | 0.073 | Nav1.7 sodium channel blocker | |||
| 0.06 | 0.026 | 0.06 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.044 | 0.01 | 0.044 | Cholesterol ester transfer protein antagonist | |||
| 0.097 | 0.064 | 0.097 | Nitric-oxide synthase inhibitor | |||
| 0.063 | 0.03 | 0.063 | Thromboxane antagonist | |||
| 0.05 | 0.017 | 0.05 | Beta adrenoreceptor agonist | |||
| 0.039 | 0.006 | 0.039 | Thyroid hormone agonist | |||
| 0.146 | 0.114 | 0.554 | Hepatoprotectant | 0.554 0.005 CID_154699837 | CID_154699837 | |
| 0.047 | 0.015 | 0.047 | Retinoid X receptor antagonist | |||
| 0.055 | 0.023 | 0.055 | Carbonic anhydrase VII inhibitor | |||
| 0.04 | 0.008 | 0.128 | Sodium/glucose cotransporter 2 inhibitor | 0.128 0.002 CID_154699837 | CID_154699837 | |
| 0.054 | 0.022 | 0.054 | Thymidylate synthase inhibitor | |||
| 0.101 | 0.07 | 0.101 | Falcipain 3 inhibitor | |||
| 0.038 | 0.007 | 0.144 | Sodium/glucose cotransporter inhibitor | 0.144 0.002 CID_154699837 | CID_154699837 | |
| 0.144 | 0.113 | 0.485 | Platelet adhesion inhibitor | 0.485 0.005 CID_154699837 | CID_154699837 | |
| 0.045 | 0.015 | 0.045 | Integrin alpha2 antagonist | |||
| 0.059 | 0.029 | 0.059 | Thromboxane A2 antagonist | |||
| 0.045 | 0.015 | 0.045 | Leukotriene C4 antagonist | |||
| 0.047 | 0.018 | 0.047 | AMPA 4 receptor antagonist | |||
| 0.063 | 0.033 | 0.063 | Alpha 1 adrenoreceptor agonist | |||
| 0.131 | 0.102 | 0.131 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.056 | 0.027 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.052 | 0.024 | 0.068 | Cytokine production stimulant | 0.068 0.008 CID_154699837 | CID_154699837 | |
| 0.096 | 0.067 | 0.096 | Protein kinase (CK2) inhibitor | |||
| 0.047 | 0.019 | 0.047 | Sphingosine kinase 1 inhibitor | |||
| 0.047 | 0.019 | 0.047 | Acid-sensing ion channel blocker | |||
| 0.041 | 0.013 | 0.041 | AMPA 3 receptor antagonist | |||
| 0.037 | 0.009 | 0.037 | Prostaglandin EP2 agonist | |||
| 0.034 | 0.007 | 0.034 | Prostaglandin F2 alpha agonist | |||
| 0.032 | 0.005 | 0.032 | Cyclin T1 inhibitor | |||
| 0.059 | 0.032 | 0.059 | Glucosylceramidase inhibitor | |||
| 0.064 | 0.037 | 0.064 | Heme oxygenase stimulant | |||
| 0.049 | 0.023 | 0.049 | Glutamate (mGluR group III) antagonist | |||
| 0.074 | 0.049 | 0.074 | Cathepsin G inhibitor | |||
| 0.193 | 0.168 | 0.193 | Thyroid hormone antagonist | |||
| 0.059 | 0.034 | 0.059 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.063 | 0.038 | 0.063 | Acetylcholine M3 receptor antagonist | |||
| 0.04 | 0.015 | 0.04 | Retinoid X alpha receptor antagonist | |||
| 0.058 | 0.033 | 0.058 | Ornithine carbamoyltransferase inhibitor | |||
| 0.05 | 0.025 | 0.05 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.034 | 0.009 | 0.034 | Integrin alpha2beta1 antagonist | |||
| 0.095 | 0.071 | 0.095 | Alpha 2c adrenoreceptor antagonist | |||
| 0.051 | 0.028 | 0.051 | Aldosterone antagonist | |||
| 0.032 | 0.008 | 0.051 | Vanilloid 2 agonist | 0.051 0.003 CID_154699837 | CID_154699837 | |
| 0.033 | 0.009 | 0.033 | Prostaglandin E2 agonist | |||
| 0.038 | 0.015 | 0.038 | Glucagon receptor antagonist | |||
| 0.057 | 0.034 | 0.057 | GABA receptor antagonist | |||
| 0.099 | 0.076 | 0.099 | Alpha 2b adrenoreceptor antagonist | |||
| 0.042 | 0.02 | 0.076 | Arginase inhibitor | 0.076 0.006 CID_154699837 | CID_154699837 | |
| 0.038 | 0.016 | 0.038 | Potassium channel small-conductance Ca-activated activator | |||
| 0.034 | 0.012 | 0.034 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.046 | 0.024 | 0.046 | Nerve growth factor antagonist | |||
| 0.105 | 0.083 | 0.214 | Alkylator | 0.214 0.023 CID_154699837 | CID_154699837 | |
| 0.034 | 0.012 | 0.034 | MAP3K8 inhibitor | |||
| 0.038 | 0.017 | 0.038 | Glutamate (mGluR4) agonist | |||
| 0.026 | 0.005 | 0.026 | Estrogen-related receptor gamma agonist | |||
| 0.065 | 0.044 | 0.084 | Interferon inducer | 0.084 0.021 CID_154699837 | CID_154699837 | |
| 0.034 | 0.014 | 0.034 | CDK4/cyclin D3 inhibitor | |||
| 0.045 | 0.025 | 0.045 | CDK5/p25 inhibitor | |||
| 0.063 | 0.043 | 0.063 | Glutamate (mGluR) agonist | |||
| 0.062 | 0.042 | 0.062 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.065 | 0.045 | 0.065 | Leukotriene antagonist | 0.06 0.051 CID_154699837 | ||
| 0.077 | 0.057 | 0.101 | Interferon agonist | 0.101 0.028 CID_154699837 | CID_154699837 | |
| 0.034 | 0.015 | 0.034 | Glutamate (mGluR2) antagonist | |||
| 0.114 | 0.095 | 0.114 | Toll-Like receptor antagonist | |||
| 0.041 | 0.022 | 0.041 | Farnesoid X receptor agonist | |||
| 0.029 | 0.01 | 0.029 | Complement factor 1s inhibitor | |||
| 0.028 | 0.01 | 0.028 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.119 | 0.101 | 0.119 | Cytidine deaminase inhibitor | |||
| 0.071 | 0.052 | 0.071 | Alpha 1b adrenoreceptor antagonist | |||
| 0.092 | 0.074 | 0.092 | MAP kinase kinase kinase inhibitor | |||
| 0.062 | 0.044 | 0.062 | I kappa B kinase 2 inhibitor | |||
| 0.03 | 0.013 | 0.03 | CC chemokine 1 receptor antagonist | |||
| 0.048 | 0.031 | 0.048 | Opioid mu receptor agonist | |||
| 0.031 | 0.015 | 0.031 | Purinergic P2Y15 antagonist | |||
| 0.108 | 0.092 | 0.108 | Tubulin antagonist | |||
| 0.091 | 0.074 | 0.091 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.023 | 0.007 | 0.037 | Antibiotic Anthracycline-like | 0.037 0.003 CID_154699837 | CID_154699837 | |
| 0.037 | 0.022 | 0.037 | Phosphoglycerate kinase inhibitor | |||
| 0.044 | 0.029 | 0.044 | Guanylate cyclase stimulant | |||
| 0.061 | 0.045 | 0.061 | NMDA receptor glycine site agonist | |||
| 0.02 | 0.004 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.053 | 0.038 | 0.053 | GABA A receptor antagonist | |||
| 0.101 | 0.086 | 0.101 | Proteasome inhibitor | |||
| 0.034 | 0.019 | 0.034 | Liver X receptor antagonist | |||
| 0.052 | 0.037 | 0.052 | Vanilloid 2 antagonist | |||
| 0.069 | 0.055 | 0.069 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.026 | 0.012 | 0.026 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.031 | 0.017 | 0.031 | Liver X receptor alpha antagonist | |||
| 0.184 | 0.169 | 0.184 | Prostaglandin dehydrogenase inhibitor | |||
| 0.05 | 0.036 | 0.05 | Antiviral (Hepatitis D) | |||
| 0.044 | 0.03 | 0.044 | Stearoyl-CoA desaturase inhibitor | |||
| 0.037 | 0.023 | 0.037 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.018 | 0.004 | 0.018 | Progesterone receptor A antagonist | |||
| 0.021 | 0.007 | 0.029 | Telomerase stimulant | 0.029 0.003 CID_154699837 | CID_154699837 | |
| 0.07 | 0.056 | 0.07 | Orexin receptor 1 antagonist | |||
| 0.04 | 0.026 | 0.04 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.043 | 0.03 | 0.043 | Carbonic anhydrase IV inhibitor | |||
| 0.044 | 0.031 | 0.044 | Sphingosine 1-phosphate receptor agonist | |||
| 0.027 | 0.014 | 0.027 | Acid ceramidase inhibitor | |||
| 0.146 | 0.134 | 0.146 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.121 | 0.109 | 0.121 | Death-associated protein kinase 1 inhibitor | |||
| 0.028 | 0.015 | 0.028 | Prostaglandin H2 antagonist | |||
| 0.021 | 0.009 | 0.021 | Alpha 2b adrenoreceptor agonist | |||
| 0.025 | 0.013 | 0.033 | Dopamine D1 agonist | 0.033 0.007 CID_154699837 | CID_154699837 | |
| 0.036 | 0.024 | 0.036 | Nicotinic acid receptor 2 agonist | |||
| 0.046 | 0.034 | 0.046 | Adenosine deaminase inhibitor | 0.041 0.04 CID_154699837 | ||
| 0.021 | 0.009 | 0.021 | G-protein-coupled receptor 120 agonist | |||
| 0.094 | 0.082 | 0.094 | Protein kinase (CK2) alpha inhibitor | |||
| 0.042 | 0.031 | 0.042 | Histamine H2 receptor agonist | |||
| 0.067 | 0.056 | 0.067 | Calcium channel L-type blocker | |||
| 0.03 | 0.018 | 0.03 | 5 Hydroxytryptamine 6 agonist | |||
| 0.031 | 0.02 | 0.031 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.037 | 0.027 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.145 | 0.135 | 0.145 | Anticonvulsant | |||
| 0.02 | 0.009 | 0.055 | Ileal bile acid transport inhibitor | 0.055 0.003 CID_154699837 | CID_154699837 | |
| 0.02 | 0.01 | 0.02 | Complement factor D inhibitor | |||
| 0.015 | 0.005 | 0.015 | Glutamate (mGluR6) agonist | |||
| 0.05 | 0.04 | 0.05 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.033 | 0.024 | 0.033 | Calcitonin receptor agonist | |||
| 0.055 | 0.046 | 0.078 | Prostaglandin EP2 antagonist | 0.078 0.028 CID_154699837 | CID_154699837 | |
| 0.038 | 0.029 | 0.038 | MAP3K5 inhibitor | |||
| 0.051 | 0.042 | 0.051 | Ribonucleotide reductase inhibitor | |||
| 0.032 | 0.023 | 0.032 | Estrogen-related receptor alpha antagonist | |||
| 0.021 | 0.013 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.089 | 0.081 | 0.089 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.028 | 0.02 | 0.028 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.017 | 0.009 | 0.017 | NMDA receptor phencyclidine site antagonist | |||
| 0.037 | 0.029 | 0.037 | Vascular adhesion protein 1 inhibitor | |||
| 0.039 | 0.031 | 0.039 | Thymidine kinase inhibitor | |||
| 0.029 | 0.021 | 0.029 | AMPA 1 receptor antagonist | |||
| 0.016 | 0.009 | 0.016 | Thromboxane A2 agonist | |||
| 0.042 | 0.035 | 0.042 | Purinergic P2Y antagonist | |||
| 0.047 | 0.04 | 0.095 | Carbonic anhydrase XII inhibitor | 0.095 0.021 CID_154699837 | CID_154699837 | |
| 0.043 | 0.037 | 0.043 | Antimetabolite | |||
| 0.022 | 0.016 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 CID_154699837 | ||
| 0.058 | 0.051 | 0.058 | NMDA receptor agonist | |||
| 0.059 | 0.052 | 0.059 | Histone deacetylase SIRT3 inhibitor | |||
| 0.098 | 0.092 | 0.098 | TRKA antagonist | |||
| 0.027 | 0.02 | 0.027 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.031 | 0.025 | 0.031 | Sirtuin 2 inhibitor | |||
| 0.18 | 0.174 | 0.18 | Thyroid hormone beta antagonist | |||
| 0.026 | 0.02 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.066 | 0.06 | 0.124 | Histone deacetylase stimulant | 0.124 0.016 CID_154699837 | CID_154699837 | |
| 0.066 | 0.06 | 0.124 | Histone deacetylase SIRT1 stimulant | 0.124 0.016 CID_154699837 | CID_154699837 | |
| 0.025 | 0.02 | 0.025 | Thymidine phosphorylase inhibitor | |||
| 0.055 | 0.05 | 0.055 | Carbonic anhydrase inhibitor | |||
| 0.034 | 0.029 | 0.034 | Glutamate (mGluR8) antagonist | |||
| 0.067 | 0.062 | 0.067 | Metalloproteinase-9 inhibitor | |||
| 0.02 | 0.016 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.043 | 0.039 | 0.043 | AMPA receptor antagonist | |||
| 0.021 | 0.017 | 0.025 | Leukotriene B4 receptor 2 antagonist | 0.025 0.012 CID_154699837 | CID_154699837 | |
| 0.053 | 0.049 | 0.053 | Cannabinoid CB1 receptor agonist | |||
| 0.009 | 0.005 | 0.009 | Thyroid hormone beta agonist | |||
| 0.216 | 0.212 | 0.216 | Transcription factor inhibitor | |||
| 0.088 | 0.084 | 0.198 | Mediator release inhibitor | 0.198 0.015 CID_154699837 | CID_154699837 | |
| 0.026 | 0.023 | 0.026 | Thrombin receptor antagonist | |||
| 0.049 | 0.045 | 0.049 | Carbonic anhydrase II inhibitor | |||
| 0.036 | 0.033 | 0.036 | Toll-Like receptor 2 agonist | 0.036 0.034 CID_154699837 | ||
| 0.164 | 0.16 | 0.436 | Peptidyltransferase inhibitor | 0.436 0.005 CID_154699837 | CID_154699837 | |
| 0.018 | 0.014 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.034 | 0.031 | 0.034 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.012 | 0.009 | 0.012 | Egl nine homolog 3 inhibitor | |||
| 0.063 | 0.06 | 0.063 | Dopamine antagonist | |||
| 0.015 | 0.012 | 0.015 | Purinergic P2Y1 agonist | |||
| 0.065 | 0.062 | 0.065 | Vanilloid antagonist | |||
| 0.015 | 0.012 | 0.015 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.03 | 0.027 | 0.03 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.054 | 0.051 | 0.076 | Lipocortins synthesis agonist | 0.076 0.016 CID_154699837 | CID_154699837 | |
| 0.011 | 0.009 | 0.011 | Thrombopoietin agonist | |||
| 0.044 | 0.042 | 0.044 | Benzodiazepine antagonist | |||
| 0.041 | 0.039 | 0.041 | Histamine H1 receptor agonist | |||
| 0.031 | 0.029 | 0.031 | Kainate receptor 2 antagonist | |||
| 0.017 | 0.015 | 0.017 | Alpha 2c adrenoreceptor agonist | |||
| 0.019 | 0.018 | 0.019 | Retinoid X beta receptor antagonist | |||
| 0.021 | 0.019 | 0.021 | Beta 1 adrenoreceptor agonist | |||
| 0.044 | 0.043 | 0.044 | Potassium channel (Inward rectifier) blocker | |||
| 0.006 | 0.004 | 0.006 | Insulin like growth factor 3 antagonist | |||
| 0.043 | 0.042 | 0.043 | Cannabinoid CB2 receptor antagonist | |||
| 0.023 | 0.022 | 0.023 | Sigma 2 receptor antagonist | |||
| 0.024 | 0.023 | 0.024 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.019 | 0.018 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.032 | 0.031 | 0.032 | Opioid delta receptor agonist | |||
| 0.031 | 0.03 | 0.031 | Melatonin receptor 1A agonist | |||
| 0.073 | 0.072 | 0.073 | I kappa B kinase inhibitor | |||
| 0.009 | 0.01 | 0.014 | Purinergic P2Y2 agonist | 0.014 0.004 CID_154699837 | CID_154699837 | |
| 0.045 | 0.047 | 0.066 | Carbonic anhydrase IX inhibitor | 0.066 0.034 CID_154699837 | CID_154699837 | |
| 0.022 | 0.044 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.011 CID_154699837 | CID_154699837 | |
| 0.103 | 0.13 | 0.235 | Diuretic | 0.235 0.034 CID_154699837 | CID_154699837 | |
| 0.051 | 0.081 | 0.124 | Neuraminidase (influenza) inhibitor | 0.124 0.011 CID_154699837 | CID_154699837 | |
| 0.047 | 0.079 | 0.065 | Transcription factor AP-1 inhibitor | 0.065 0.036 CID_154699837 | CID_154699837 | |
| 0.014 | 0.049 | 0.048 | Motilin receptor agonist | 0.048 0.006 CID_154699837 | CID_154699837 | |
| 0.181 | 0.217 | 0.544 | Immunosuppressant | 0.544 0.022 CID_154699837 | CID_154699837 | |
| 0.014 | 0.055 | 0.076 | Protein 30S ribosomal subunit inhibitor | 0.076 0.004 CID_154699837 | CID_154699837 | |
| 0.061 | 0.105 | 0.133 | Falcipain 2 inhibitor | 0.133 0.036 CID_154699837 | CID_154699837 | |
| 0.063 | 0.108 | 0.135 | Falcipain inhibitor | 0.135 0.038 CID_154699837 | CID_154699837 | |
| 0.011 | 0.057 | 0.022 | Corticosteroid-like | 0.022 0.014 CID_154699837 | CID_154699837 | |
| 0.075 | 0.122 | 0.147 | DNA polymerase I inhibitor | 0.147 0.051 CID_154699837 | CID_154699837 | |
| 0.008 | 0.058 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.011 CID_154699837 | CID_154699837 | |
| 0.038 | 0.09 | 0.056 | Factor III inhibitor | 0.056 0.022 CID_154699837 | CID_154699837 | |
| 0.036 | 0.088 | 0.111 | Glucose-6-phosphate translocase inhibitor | 0.111 0.005 CID_154699837 | CID_154699837 | |
| 0.173 | 0.243 | 0.352 | Antiobesity | 0.352 0.086 CID_154699837 | CID_154699837 | |
| 0.029 | 0.108 | 0.103 | Neuraminidase inhibitor | 0.103 0.014 CID_154699837 | CID_154699837 | |
| 0.107 | 0.189 | 0.158 | P-glycoprotein inhibitor | 0.158 0.104 CID_154699837 | CID_154699837 | |
| 0.03 | 0.122 | 0.12 | Factor IXa inhibitor | 0.12 0.006 CID_154699837 | CID_154699837 | |
| 0.072 | 0.171 | 0.385 | Thrombolytic | 0.385 0.013 CID_154699837 | CID_154699837 | |
| 0.028 | 0.134 | 0.247 | Antineoplastic antibiotic | 0.247 0.015 CID_154699837 | CID_154699837 | |
| 0.02 | 0.129 | 0.095 | Antibiotic Aminoglycoside-like | 0.095 0.003 CID_154699837 | CID_154699837 | |
| 0.023 | 0.134 | 0.054 | Microtubule stabilization | 0.054 0.022 CID_154699837 | CID_154699837 | |
| 0.021 | 0.137 | 0.144 | Protein 50S ribosomal subunit inhibitor | 0.144 0.007 CID_154699837 | CID_154699837 | |
| 0.137 | 0.259 | 0.348 | Angiogenesis inhibitor | 0.348 0.072 CID_154699837 | CID_154699837 | |
| 0.021 | 0.171 | 0.459 | Selectin antagonist | 0.459 0.003 CID_154699837 | CID_154699837 | |
| 0.018 | 0.175 | 0.061 | Neuraminidase (Influenza A) inhibitor | 0.061 0.012 CID_154699837 | CID_154699837 | |
| 0.005 | 0.164 | 0.05 | Squalene synthetase inhibitor | 0.05 0.014 CID_154699837 | CID_154699837 | |
| 0.028 | 0.19 | 0.078 | DNA gyrase inhibitor | 0.078 0.028 CID_154699837 | CID_154699837 | |
| 0.001 | 0.17 | 0.017 | Antibiotic Macrolide-like | 0.017 0.008 CID_154699837 | CID_154699837 | |
| 0.038 | 0.226 | 0.148 | DNA intercalator | 0.148 0.043 CID_154699837 | CID_154699837 | |
| 0.039 | 0.229 | 0.132 | ATPase (Vacuolar H+) inhibitor | 0.132 0.013 CID_154699837 | CID_154699837 | |
| 0.084 | 0.284 | 0.354 | Vasodilator | 0.354 0.032 CID_154699837 | CID_154699837 | |
| 0.014 | 0.253 | 0.039 | Toll-Like receptor 4 agonist | 0.039 0.005 CID_154699837 | CID_154699837 | |
| 0.098 | 0.365 | 0.555 | Immunomodulator | 0.555 0.016 CID_154699837 | CID_154699837 | |
| 0.016 | 0.324 | 0.075 | Nitric oxide donor | 0.075 0.027 CID_154699837 | CID_154699837 | |
| 0.043 | 0.402 | 0.365 | Platelet antagonist | 0.365 0.035 CID_154699837 | CID_154699837 | |
| 0.037 | 0.404 | 0.363 | Cell adhesion inhibitor | 0.363 0.006 CID_154699837 | CID_154699837 | |
| 0.021 | 0.424 | 0.197 | Cell adhesion molecule inhibitor | 0.197 0.01 CID_154699837 | CID_154699837 | |
| 0.004 | 0.475 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.011 CID_154699837 | CID_154699837 | |
| 0.031 | 0.583 | 0.094 | T cell inhibitor | 0.094 0.032 CID_154699837 | CID_154699837 | |
| 0.01 | 0.704 | 0.271 | Anticoagulant | 0.271 0.034 CID_154699837 | CID_154699837 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |